Related Experiment Video
Updated: Aug 30, 2025

In Vivo Augmentation of Gut-Homing Regulatory T Cell Induction
Published on: January 22, 2020
Vitamin D receptor activation is a feasible therapeutic target to impair adrenocortical tumorigenesis
Ana Carolina Bueno1, Candy Bellido More1, Junier Marrero-Gutiérrez2
1Department of Pediatrics, Ribeirao Preto Medical School, University of Sao Paulo, Ribeirao Preto, SP, Brazil.
Objective:
To evaluate the therapeutic potential of vitamin D receptor (VDR) signaling in adrenocortical carcinoma (ACC) cells.
Methods:
We evaluated VDR's methylation pattern in H295R ACC cells, and investigated the effects of calcitriol and seocalcitol treatments on adrenocortical tumorigenesis.
Results:
VDR was hypermethylated and underexpressed in basal H295R cells. Treatments with calcitriol and seocalcitol restored VDR signaling, resulted in antiproliferative effects, and impaired Wnt/B-catenin signaling. RNAseq of treated cells demonstrated VDR activation on steroid hormones biosynthesis and Rap1 signaling, among others. In vivo, seocalcitol constrained the growth of H295R xenografts and reduced autonomous tumor steroid secretion without hypercalcemia-associated side effects.
Conclusions:
H295R cells present VDR hypermethylation, which can be responsible for its underexpression and signaling inactivation under basal conditions. VDR signaling promoted antiproliferative effects in vitro and in vivo, suggesting that it may be a potential therapeutic target for ACC and a valuable tool for patient's clinical management.
Insights
Vitamin D Receptor (VDR) signaling shows therapeutic potential in adrenocortical carcinoma (ACC). Restoring VDR function inhibits tumor growth and steroid secretion, offering a new treatment avenue for ACC.
Area of Science:
- Endocrinology
- Oncology
- Molecular Biology
Background:
- Adrenocortical carcinoma (ACC) is a rare endocrine malignancy.
- Dysregulation of Vitamin D Receptor (VDR) signaling is implicated in cancer development.
- Understanding VDR's role in ACC is crucial for therapeutic development.
Purpose of the Study:
- To investigate the therapeutic potential of VDR signaling in ACC.
- To evaluate the effects of VDR activation on ACC cell behavior and tumorigenesis.
- To explore VDR's methylation status and its impact on VDR expression in ACC.
Main Methods:
- Assessed VDR methylation and expression in H295R ACC cells.
- Treated ACC cells with calcitriol and seocalcitol to modulate VDR signaling.
- Utilized RNA sequencing to analyze gene expression changes post-treatment.
- Evaluated the in vivo effects of seocalcitol on ACC xenografts.
Main Results:
- VDR was found to be hypermethylated and underexpressed in basal ACC cells.
- Calcitriol and seocalcitol treatments restored VDR signaling, exhibiting antiproliferative effects.
- VDR activation modulated steroid hormone biosynthesis and Rap1 signaling pathways.
- Seocalcitol inhibited tumor growth in vivo without causing hypercalcemia.
Conclusions:
- VDR hypermethylation contributes to VDR underexpression and signaling inactivation in ACC.
- VDR signaling demonstrates significant antiproliferative effects in vitro and in vivo.
- VDR represents a promising therapeutic target for adrenocortical carcinoma treatment.
Related Concept Videos
Role of Skin in Vitamin D Synthesis
The solar UV B rays (290-315 nm) are absorbed by the skin, and 7-dehydrocholesterol (provitamin D3) photolyzes it to previtamin D3, which undergoes a rapid transformation to vitamin...
Receptor Downregulation in MVBs
The EGFR can initiate signaling pathways that lead to cell proliferation, migration, and differentiation. Overexpression of EGFR stimulates cells to proliferate. Excessive EGFR...
mTOR Signaling and Cancer Progression
The mTOR pathway or the...
Mitogens and the Cell Cycle
Abnormal Proliferation
Connective Tissue Cell Types
Fat cells (adipocytes), smooth muscle cells (myoblasts), and bone cells (osteoblasts) are some connective tissue cell types. Some immune system cells...

